Zimmer Biomet (ZBH) PT Raised to $187 at Needham & Company, Adds to Conviction List
Tweet Send to a Friend
Needham & Company analyst Mike Matson raised the price target on Zimmer Biomet (NYSE: ZBH) to $187.00 (from $170.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
